Kriya Therapeutics, Inc.
Clinical trials sponsored by Kriya Therapeutics, Inc., explained in plain language.
-
Gene therapy injection aims to slow vision loss from dry AMD
Disease control Recruiting nowThis study tests a new gene therapy (VV-14295) given as an injection into the eye for people with geographic atrophy, a form of advanced dry age-related macular degeneration that causes blind spots. The goal is to see if it is safe and can slow the growth of these spots. About 62…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New shot-and-pill combo aims to calm facial nerve pain
Symptom relief Recruiting nowThis early-stage study tests whether an injection of KRIYA-748 followed by a daily varenicline pill is safe and can reduce pain and attack frequency in people with trigeminal neuralgia, a condition causing severe facial pain. About 24 adults with classic trigeminal neuralgia will…
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 08:31 UTC